Novo Nordisk’s Pipeline and Buyback Offer Twin Props as Wegovy Prescriptions Cool
For Novo Nordisk, the contrast between long-term promise and near-term pressure has rarely been starker. On one side,…
European Lithium Secures Merger Funding but Faces Twin Project Pressures from Greenland to Austria
European Lithium secures A$45M to meet merger cash requirement, but ASX investigation, executive conflicts, and permit setbacks in…
Canadian Generic Launch and Q1 Results Loom
Health Canada authorizes Dr. Reddy’s biosimilar semaglutide, threatening Novo Nordisk’s Ozempic revenue as share buyback reaches 3.44 billion…